公司治理
全球治理
抗性(生态学)
面子(社会学概念)
抗生素耐药性
心理干预
业务
政治学
公共关系
经济
抗生素
社会学
管理
生态学
生物
医学
微生物学
社会科学
精神科
作者
Francesco Ciabuschi,Enrico Baraldi,Olof Lindahl
标识
DOI:10.5465/amp.2019.0018
摘要
Humanity is facing a global threat caused by growing antibiotic resistance. If the current lack of innovation in antibiotics persists, we will face a doomsday scenario with drastic implications for society, health, and business worldwide. In this study, we examine international multisectoral partnerships (IMSPs), one of the policy interventions introduced to incentivize the antibiotic innovation necessary to avoid such a scenario. Based on insights from three recently launched antibiotics IMSPs, we present their key features and argue that such partnerships represent a novel type of organizational form and governance, different from others discussed in previous research. Specifically, antibiotics IMSPs are interorganizational structures showing great governance complexity, strong centralized control, strict boundaries, and formalization of roles and rules. We discuss how antibiotics IMSPs differ from other partnerships dealing, for instance, with the environmental global challenge, and their usefulness in other contexts where similar uncertain, risky, urgent, and complex tasks need to be faced. We conclude with implications for theory as well as for policy and managerial practice, along with avenues for future research.
科研通智能强力驱动
Strongly Powered by AbleSci AI